DEFINE: A Phase IIa Randomised Controlled Trial to Evaluate Repurposed Treatments for COVID-19

E Gaughan, T Quinn, A Bruce, J Antonelli, V Young, J Mair, A Akram, N Hirani, O Koch, C Mackintosh, J Norrie, J Dear, K Dhaliwal
doi: https://doi.org/10.1101/2021.05.20.21257513

Data Availability

Scientific publications and the sharing of clinical data generated as part of this trial is crucial to better understanding COVID-19 and developing new treatments. As such, the results of each study arm will be published as soon as the treatment arm has finished recruitment, data has been cleaned and any outstanding patient safety follow- ups completed. External datasets and supplementary online material will be avaialble.

Back to top
Posted May 23, 2021.
Download PDF
Data/Code
Email
DEFINE: A Phase IIa Randomised Controlled Trial to Evaluate Repurposed Treatments for COVID-19
E Gaughan, T Quinn, A Bruce, J Antonelli, V Young, J Mair, A Akram, N Hirani, O Koch, C Mackintosh, J Norrie, J Dear, K Dhaliwal
medRxiv 2021.05.20.21257513; doi: https://doi.org/10.1101/2021.05.20.21257513
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area